Mesenteric Castleman's disease masquerading as inflammatory bowel disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 27, Issue 5, 1998, Pages 589-592

  Rodefeld, Mark D ^c   Sterkel, Randy ^c   Keating, James P ^c   Kane, Robert E ^a   DeMello, Daphne E ^a   Langer, Jacob C ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST LOUIS CHILDREN S HOSPITAL   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; FERROUS SULFATE; OLSALAZINE; PREDNISONE;

ABDOMINAL PAIN; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTHRALGIA; ARTICLE; CASE REPORT; COLON BIOPSY; COLONOSCOPY; ENTERITIS; ERYTHROCYTE SEDIMENTATION RATE; HISTOPATHOLOGY; HUMAN; HYPERGAMMAGLOBULINEMIA; LAPAROTOMY; MALE; MICROCYTIC ANEMIA; PRIORITY JOURNAL; SCHOOL CHILD; ULCERATIVE COLITIS;

CHILD; COLITIS, ULCERATIVE; COLONOSCOPY; DIAGNOSIS, DIFFERENTIAL; GIANT LYMPH NODE HYPERPLASIA; HUMANS; MALE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031724914     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199811000-00017     Document Type: Article

References (28)

1. Castleman B, Towne VW. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 40011. N Engl J Med 1954;250:26-30.
2. Castleman B, Iverson L, Menendez V. Localized mediastinal lymph-node hyperplasia resembling thymoma. Cancer 1956;9: 822-30.
3. Lee S, Rosner F, Rivero I, Feldman F, Hurwitz A. Refractory anemia with abnormal iron metabolism. Its remission after resection of hyperplastic mediastinal lymph nodes. N Engl J Med 1965; 272:761-6.
4. Neerhout RC, Larson W, Mansur P. Mesenteric lymphoid hamartoma associated with chronic hypoferremia, anemia, growth failure, and hyperglobulinemia. N Engl J Med 1969;280:922-5.
5. Boxer LA, Boxer GJ, Flair RC, Engstrom PF, Brown GS. Angiomatous lymphoid hamartoma associated with chronic anemia, hypoferremia, and hypergammaglobulinemia. J Pediatr 1972;81:66-70.
6. Buchanan G, Chipman JJ, Hamilton BL, Daughaday WH. Angiomatous lymphoid hamartoma: Inhibitory effects on erythropoiesis. growth and primary hemostasis. J Pediatr 1981;99:382-8.
7. Powell RW, Lightsey AL, Thomas WJ, Marsh WL. Castleman's disease in children. J Pediatr Surg 1986;21:678-82.
8. Salisbury JR. Castleman's disease in childhood and adolescence: Report of a case and review of literature. Pediatr Pathol 1990;10: 609-15.
9. Keller A, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972;29:670-83.
10. Shroff VJ, Gilchrist BF, DeLuca FG, McCombs HL, Wesselhoeft CW. Castleman's disease presenting as a pediatric surgical problem. J Pediatr Surg 1995;30:745-7.
11. Garber SJ, Shaw DG. Case report: The ultrasound and computed tomography appearance of mesenteric Castleman disease. Clin Radiol 1991;43:429-30.
12. Burgert EO, Gilchrist G, Fairbanks VF, Lynn HB, Dukes PP, Harrison EG. Intra-abdominal, angiofollicular lymph node hyperplasia (plasma cell variant) with antierythropoietic factor. Mayo Clin Proc 1975;50:542-6.
13. Hung I, Kuo T, Lin J. New observations in a child with angiofollicular lymph node hyperplasia (Castleman's disease) originated from the mesenteric root. Am J Pediatr Hematol Oncol 1992;14: 255-60.
14. Ferreiros J, Leon NG, Mata MI, Casanova R, Pedrosa CS, Cuevas A. Computed tomography in abdominal Castleman's disease. J Comput Assist Tomogr 1989;13:433-6.
15. De Heer-Groen TA, Prakken ABJ, Bax NMA, van Dijken P. Iron therapy resistant microcytic anemia in a 13-year-old girl with Castleman disease. Eur J Pediatr 1996;155:1015-7.
16. Miller JS, Miller JJ. Benign giant lymph node hyperplasia presenting as fever of unknown origin. J Pediatr 1975;87:237-9.
17. Gudmundsen TE, Kolbenstvedt A. Artenography of Castleman tumour of the mesentery. Br J Radiol 1981;54:422-3.
18. Humphreys SR, Holley KE, Smith LH, McIlrath DC. Mesenteric angiofollicular lymph node hyperplasia (lymphoid hamartoma) with nephrotic syndrome. Mayo Clin Proc 1975;50:317-21.
19. Bjarnason I, Cotes PM, Knowles S, Reid C, Wilkins R, Peters T. Giant lymph node hyperplasia (Castleman's disease) of the mesentery. Gastroenterology 1984;87:216-23.
20. Pilon VA, Gomez LG, Butler JJ. Systemic amyloidosis associated with a benign mesenteric lymphoid mass. Am J Clin Pathol 1982; 78:112-6.
21. Kahn LB, Ranchod M, Stable DP, King H, Yudelman I. Giant lymph node hyperplasia with haematological abnormalities. S Afr Med J 1973;47:811-6.
22. Garcia-San Miguel J, Rozman C, Palacin A, Nomdedeu B. Mesenteric hyaline plasma cell lymph node hyperplasia with amyloid deposits. Arch Intern Med 1981;141:261-3.
23. Yoshizaki K, Matsuda T, Nishimoto N, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989;74:1360-7.
24. Leger-Ravet MB. Peuchman M, Devergne O, et al. Interleukin-6 gene expression in Castleman's disease. Blood 1991;78:2923-30.
25. Brandt SJ, Bodine DM, Dunbar CE, Nienhuis AW. Dysregulated interleukin-6 expression produces a syndrome resembling Castleman's disease in mice. J Clin Invest 1990;86:592-9.
26. Beck JT, Hsu SM, Wijdenes J, et al. Alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 1994;33:602-5.
27. Raab Y, Hallgren R, Gerdin B. Enhanced intestinal synthesis of interleukin-6 is related to the disease severity and activity in ulcerative colitis. Digestion 1994;55:44-9.
28. Holtkamp W, Stollberg T, Reis HE. Serum interleukin-6 is related to disease activity but not disease specificity in inflammatory bowel disease. J Clin Gastroenterol 1995;20:123-6.